About Us
Partnering in Potential, Investing in Innovation.
About What If-Connect
Decades of Expertise. Proven Results. Tailored Solutions.
Our extensive background in the boardrooms of leading international organizations equips us to implement the "What If" strategic plans that are often discussed but rarely executed. If you know, you know.
Fueled by our passion for results, entrepreneurial spirit, and vast network, we are committed to helping your company turn big dreams into reality. We make the impossible—possible.
Our Core Values
Ready to Get Started?
Let’s embark on this journey together!
Project Lead
Doug Crawshaw
Canadian Distributor
Coleman First Aid and Coleman Repellents
Project Lead
Doug Crawshaw
With over 30 years of experience in the pharmaceutical industry, Doug has established himself as a seasoned leader with a proven track record of success. His career spans more than two decades at renowned multinational companies, including Baxter, Schering-Plough, Merck, and Bayer. Throughout his tenure, Doug has excelled in various roles, leading manufacturing, business intelligence, supply chain management, and project launch functions. He was also an integral part of the Merck country leadership teams for both Canada and Latin America Hub headquerted in Mexico.
In 2017, Doug founded What If Connect (WIC) , a consultancy that leverages his extensive expertise and global network of experts focussing on projects that truly matter. WIC has concentrated on Mergers and Acquisitions, Business Development, Fundraising and increasing Product Dstribution of select Brands across Canadian, US, and European markets.
Follow the attached link for full business and educational highlights. www.linkedin.com/in/doug-crawshaw-3a90071aF
Regulatory Lead
Scott Sawler
20+ Years Policy and Management Experience
Regulatory Oversight on Iconic Global Brands
Coppertone, hydraSense, Claritin, Dr.Scholl's
Regulatory Lead
Scott Sawler
Scott Sawler possesses over 30 years of experience in the regulated health product sector, including serving as President of Canadian Regulatory Affairs for the Drug Safety Institute and holding Director General (DG) positions at Health Canada. As Director General of the Marketed Health Products Directorate (MHPD), he led the Directorate responsible for conducting comprehensive risk-benefit assessments of marketed health products and developing policies to ensure their effective regulation.
Before this role, Scott served as the Director General of the Natural and Non-prescription Health Products Directorate (NNHPD), successfully guiding the program through a period of significant transition. During his tenure, he re-established the Directorate’s strategic vision, implemented comprehensive policy reforms, and streamlined management systems to enhance operational efficiency and restore the program’s effectiveness.
In addition to his extensive government and industry experience, Scott is an Associate Professor at Carleton University, where he contributes his regulatory expertise to developing and delivering academic programming in the health and life sciences sector.
Scott brings extensive senior executive experience in clinical trial management, government, and regulatory affairs, with a career spanning pharmaceutical companies, health professional associations, and non-governmental organizations.
His academic credentials include a Master of Laws (LL.M.) from Osgoode Hall Law School at York University, a Master of Business Administration (M.B.A.) from Université Laval, a Bachelor of Laws (LL.B.) from the University of Ottawa, and a Bachelor of Science (B.Sc.).
Regulatory Lead
Scott Sawler
Scott Sawler possesses over 30 years of experience in the regulated health product sector, including serving as President of Canadian Regulatory Affairs for the Drug Safety Institute and holding Director General (DG) positions at Health Canada. As Director General of the Marketed Health Products Directorate (MHPD), he led the Directorate responsible for conducting comprehensive risk-benefit assessments of marketed health products and developing policies to ensure their effective regulation.
Before this role, Scott served as the Director General of the Natural and Non-prescription Health Products Directorate (NNHPD), successfully guiding the program through a period of significant transition. During his tenure, he re-established the Directorate’s strategic vision, implemented comprehensive policy reforms, and streamlined management systems to enhance operational efficiency and restore the program’s effectiveness.
In addition to his extensive government and industry experience, Scott is an Associate Professor at Carleton University, where he contributes his regulatory expertise to developing and delivering academic programming in the health and life sciences sector.
Scott brings extensive senior executive experience in clinical trial management, government, and regulatory affairs, with a career spanning pharmaceutical companies, health professional associations, and non-governmental organizations.
His academic credentials include a Master of Laws (LL.M.) from Osgoode Hall Law School at York University, a Master of Business Administration (M.B.A.) from Université Laval, a Bachelor of Laws (LL.B.) from the University of Ottawa, and a Bachelor of Science (B.Sc.).